Loading

PeerCurrent.com|Stay current with the people and research shaping what comes next.

About Privacy Terms Support

PeerCurrent

PcPeerCurrent

Your Feed AI Summary Saved Board Expert Discussion This Week in Your Field

Follows Journals Trials Guidelines Markets

Set your cadence Alerts Settings Help

Back to follows

Clinical trial

NCT07604571

1 development in the corpus

NCT07604571

Following this puts new work involving it at the top of your briefing, with a note saying why it is there. Links are taken from the source record, never inferred.

For You Latest Breakthroughs Trials1 Reviews Guidelines

Latest

Everything in the corpus, newest first.

SEP 4, 2026 · PHASE 1 TRIAL

Study of IEV407 as Single Agent or in Combination in Patients With Advanced HR+/HER2- Breast Cancer

ClinicalTrials.gov

This is a Phase 1 safety and tolerability study in early recruitment with no results posted; it is designed to evaluate dose-limiting toxicities and adverse events, not efficacy.

PreliminaryIEV407 Letrozole Advanced HR+/HER2 Breast Cancer

Reported

Planned enrollment194

PhasePhase 1

Primary outcome: Dose-limiting to…28 days

PeerCurrent.com|Stay current with the people and research shaping what comes next.

About Privacy Terms Support